Viewing Study NCT05215405


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:09 AM
Study NCT ID: NCT05215405
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-02-03
First Post: 2022-01-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Sponsor: Kathleen Ludwig
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module